Ombudsman Regulations (Amendment)

Legislation au F1998B00044 Regulations Not in force Legislative Instrument

Legislation content

Ombudsman Regulations (Amendment) 1998 No. 47

EXPLANATORY STATEMENT

Statutory Rules 1998 No. 47

Issued by the Authority of the Prime Minister

Ombudsman Act 1976

Ombudsman Regulations (Amendment)

Section 5 of the Ombudsman Act 1976 (the Act) directs the Ombudsman to investigate complaints against prescribed authorities. Section 3 defines "prescribed authority" with reference to subsection 3AB(1) of the Act, which provides that a Commonwealth-controlled company is a prescribed authority unless it is excluded by certain transitional provisions or, under the regulations, is to be taken not to be a prescribed authority.

Under the Health Insurance Commission (Reform and Separation of Functions) Act 1997 (the Separation Act), Medibank Private is in the process of being separated from the Health Insurance Commission and becoming a distinct entity (the new Medibank Private), operating as a Commonwealth-controlled company. When the process is completed it will be competing directly with private health insurers.

The purpose of the regulations is to remove the new Medibank Private from the Commonwealth Ombudsman's jurisdiction. The new Medibank Private, like other private insurers, then becomes subject only to the jurisdiction of the Private Health Insurance Complaints Commissioner (PHICC), a statutory officer established under the National Health Act 1953. Both the Health Insurance Commission and the Ombudsman's office have approved this change. The Separation Act includes a transitional provision preserving any complaints and investigations on foot over the period of the changeover.

Pursuant to section 5 of the Separation Act, the Minister for Health and Family Services declared on 26 February 1998 that the nominated company for Part 2 of the Separation Act would be Medibank Limited ACN 080 890 259. This was gazetted on 4 March 1998. The name Medibank Limited is being used as an interim measure, as the name 'Medibank Private' is presently registered with the Australian Securities Commission and the ultimate intention is to name the new Medibank Private 'Medibank Private Limited'. The name Medibank Private must be deregistered before the name Medibank Private Limited can be registered. Once registered, the Minister will declare that the nominated company to be Medibank Private Limited.

The regulations commence on gazettal.

 

Overview

The Ombudsman Regulations (Amendment) 1998 No. 47, issued under the authority of the Prime Minister, aim to amend the Ombudsman Regulations in accordance with the Ombudsman Act 1976. The purpose of these amendments is to exclude the new Medibank Private, a Commonwealth-controlled company, from the jurisdiction of the Commonwealth Ombudsman. This change aligns with the transition of Medibank Private from the Health Insurance Commission to a distinct entity, as stipulated by the Health Insurance Commission (Reform and Separation of Functions) Act 1997. By removing Medibank Private from the Ombudsman's purview, the entity will be subject only to the jurisdiction of the Private Health Insurance Complaints Commissioner (PHICC), as established under the National Health Act 1953. This amendment facilitates the new Medibank Private's transition into the private health insurance market, ensuring it operates under appropriate regulatory oversight. Both the Health Insurance Commission and the Ombudsman's office have endorsed this regulatory shift.

Scope and Application

The Ombudsman Regulations (Amendment) 1998 No. 47 is an amendment to the Ombudsman Act 1976 that alters the jurisdiction of the Commonwealth Ombudsman over the new Medibank Private, a Commonwealth-controlled company being separated from the Health Insurance Commission as per the Health Insurance Commission (Reform and Separation of Functions) Act 1997. This amendment specifically excludes the new Medibank Private from the definition of a "prescribed authority" under section 3 of the Ombudsman Act, thereby removing it from the Ombudsman's investigative jurisdiction. Instead, the new Medibank Private, once fully operational and competing with private health insurers, will be subject to the jurisdiction of the Private Health Insurance Complaints Commissioner established under the National Health Act 1953. This jurisdictional shift ensures that the new Medibank Private is regulated in the same manner as other private health insurers, providing a consistent regulatory framework. Both the Health Insurance Commission and the Ombudsman's office have endorsed this transition, and the Separation Act includes provisions to preserve ongoing complaints and investigations during the changeover period. The regulations are effective from the date of gazettal.

Key Provisions

The Ombudsman Regulations (Amendment) 1998 No. 47 primarily focuses on modifying the scope of the Ombudsman's jurisdiction under the Ombudsman Act 1976. Specifically, Section 5 of the Ombudsman Act 1976 mandates the Ombudsman to investigate complaints against prescribed authorities, but the amended regulations exclude the new Medibank Private from this scope. This exclusion is a direct response to the Health Insurance Commission (Reform and Separation of Functions) Act 1997, which details the separation of Medibank Private from the Health Insurance Commission and its transition into a distinct entity operating as a Commonwealth-controlled company. By virtue of these regulations, the new Medibank Private will no longer be subject to the Ombudsman's oversight and instead will fall under the jurisdiction of the Private Health Insurance Complaints Commissioner (PHICC) as per the National Health Act 1953. The regulations impose specific obligations on the Ombudsman and the new Medibank Private. For the Ombudsman, the primary obligation is to cease any investigations or complaints that pertain to the new Medibank Private once the regulations come into effect. Conversely, the new Medibank Private must now comply with the regulatory oversight of the PHICC, ensuring that any consumer complaints or disputes are handled according to the provisions under the National Health Act 1953. This shift in jurisdiction necessitates that both entities and their respective oversight bodies coordinate effectively to maintain a seamless transition for consumers. In terms of legal consequences, the regulations do not explicitly outline new offences or penalties. However, any breach of the amended jurisdictional provisions could potentially lead to legal challenges or disputes regarding the appropriate authority to handle complaints. The Ombudsman and the new Medibank Private must ensure strict adherence to the new regulatory framework to avoid any ambiguity or conflict in their respective roles. Non-compliance with the regulations could result in legal actions to clarify jurisdiction or accountability, although the specific penalties are not detailed within the text of the regulations. The overarching aim is to ensure that the transition is legally sound and that consumer rights are protected under the appropriate oversight body.

Legal classification tags

Area of Law
Administrative Law
Instrument
Regulation
Concepts
Definitions & Interpretation
Regulatory Standards
Offence Provisions

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.